Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on MPLA Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101081851A reveals a high-yield 4-step route for alpha-aza spirocyclic templates, offering significant cost reduction in API manufacturing and reliable supply chain scalability.
Patent CN113527050B reveals a novel Nap-protected MPLA intermediate synthesis. This method eliminates hydrogenation, ensuring high purity and scalable supply for vaccine adjuvant manufacturing.